Clinical Trials
- Orthopaedics, Muscle & Bone
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus (PHOENYCS GO)
- Ages16 years and older
- GenderBoth
- Skin/Dermatology, Orthopaedics, Muscle & Bone
The Scleroderma Patient-centered Intervention Network (SPIN)
- Ages18 years and older
- GenderBoth
- Immune System
Yale Lupus and Connective Tissue Disease Bio-Repository / Yale Rheumatology Bio-Repository
- Ages18 years and older
- GenderBoth
- Immune System
Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)
- Ages18 years - 75 years
- GenderBoth
- Skin/Dermatology, Immune System
Genome Research in African American Scleroderma Patients (GRASP Study)
- Ages18 years and older
- GenderBoth
- Skin/Dermatology
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata (AZURE)
- Ages18 years - 75 years
- GenderBoth
- Orthopaedics, Muscle & Bone, Immune System
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE (NAIVE)
- Ages18 years - 70 years
- GenderBoth
- Arthritis
Yale Rheumatology Program Patient Registry and Bio-Repository
- Ages18 years - 99 years
- GenderBoth
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
- Ages18 years and older
- GenderBoth
- Children's Health, Immune System, Arthritis
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Ages2 years - 21 years
- GenderBoth